Cheshire and Merseyside Cancer Alliance

Name

Cheshire and Merseyside Cancer Alliance

Legal name

Cheshire and Merseyside Cancer Alliance

Website

https://cmcanceralliance.nhs.uk

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Cancer care coordination and NHS cancer pathway services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Thoracic (Lung) Oncology (HLAKAFAL), Head & Neck Surgery (ENT Oncology) (HLAKAMAF), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

Keywords

• Cancer care coordination
• NHS cancer pathways
• Cancer screening programmes
• Clinical pathway improvement
• Healthcare workforce training

Headquarters

HQ city

Birkenhead

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. NHS England/Improvement Funding: Funded by NHSE/I and hosted by The Clatterbridge Cancer Centre NHS Foundation Trust. Receives data from hospitals and healthcare organisations regarding cancer patients.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Cheshire and Merseyside Cancer Alliance is an NHS public body that coordinates, leads, and drives improvements in cancer services across nine areas in Cheshire and Merseyside. It delivers early diagnosis programmes (including Targeted Lung Health Checks via mobile CT scanning and FIT testing), standardised clinical pathways (Lynch syndrome, Emergency Brain Tumour, Rapid Diagnostic Services, CURE smoking cessation, Personalised Stratified Follow-Up), personalised care, the Cancer Academy e-learning platform for cancer professionals, the Cancer Surgical Hub for urgent surgery coordination, and community engagement for health inequality reduction across the region.

Product overview

Cheshire and Merseyside Cancer Alliance is a NHS cancer coordination organisation rather than a software product company. It operates as a programme-based alliance delivering cancer services across prevention, early detection, screening, treatment, and aftercare. The portfolio includes The Cancer Academy (an online learning platform for cancer professionals), the Targeted Lung Health Checks programme (mobile CT screening), the Early Diagnosis Community Engagement programme (grassroots outreach), and the Genomics Programme. Supporting services include Personalised Stratified Follow-Up, Lynch Syndrome Optimal Pathways, Emergency Brain Tumour Pathway, CURE smoking cessation project, Cancer Surgical Hub, ACCEND workforce development programme, and Faecal Immunochemical Testing diagnostics. These programmes work together to achieve the NHS Long Term Plan ambition of improving early cancer diagnosis and patient outcomes across the Cheshire and Merseyside region.

Differentiator

Problem solved

Functional benefit

Brands

• The Cancer Academy: An online education and resource hub for cancer health professionals providing excellence in cancer education for people working in cancer treatment, care and planning in healthcare or community settings.

Products and services

• The Cancer Academy Online learning platform for cancer healthcare professionals providing training, education, resources, and professional development. Includes a personalised dashboard, digital ePortfolio for tracking training attendance, news, upcoming events calendar, and 60+ training resources such as recorded webinars and e-learning modules. For cancer Support Workers, Cancer Navigators, and primary care staff.
• Targeted Lung Health Checks (TLHC) Flagship NHS lung cancer screening programme using mobile CT scanning vans to detect lung cancers at earlier, more treatable stages in people aged 55-74 who are current or former smokers. Combined with integrated smoking cessation and spirometry. For residents of Cheshire and Merseyside in eligible age and smoking history groups.
• Early Diagnosis Community Engagement Programme Grassroots community outreach programme that empowers local organisations to spread cancer awareness messages, improve understanding of cancer signs and symptoms, and encourage appropriate health-seeking behaviour across Cheshire and Merseyside. Delivered via VCSE organisations in Halton, Knowsley, and Warrington. For diverse and underserved communities.
• Genomics Programme Programme integrating genomic medicine into cancer services, supporting clinicians with genomics knowledge and standardising genomic testing pathways across the region for personalised cancer treatment. Works with the North West Genomic Medicine Service Alliance and the North West Genomics Laboratory Hub.
• Lynch Syndrome Optimal Pathways Quality improvement project implementing standardised pathways for Lynch syndrome testing in colorectal and endometrial cancer patients, including reflex immunohistochemistry (IHC) testing and mainstreaming of genetic germline testing. Improved testing compliance from less than 20% baseline to over 93%.
• Emergency Brain Tumour Pathway Formalised care pathway ensuring patients diagnosed with brain tumours in A&E have coordinated care with specialist teams from point of diagnosis, with appropriate support and information throughout the diagnostic journey. Developed in collaboration between The Walton Centre and St Helens & Knowsley Teaching Hospitals NHS Trust.
• Personalised Stratified Follow-Up (PSFU) Follow-up care pathway for cancer patients post-treatment that empowers patients through education to improve self-management and understanding of their personalised care plan, reducing unnecessary outpatient visits and tailoring follow-up to risk.
• CURE Project Smoking cessation programme implemented in secondary care settings to support patients to quit smoking and reduce cancer risk. For inpatients across Cheshire and Merseyside trusts.
• Cheshire and Merseyside Cancer Surgical Hub Single waiting list and surgical coordination hub overseeing urgent cancer surgery across the region, ensuring equal access to surgery for cancer patients regardless of where they live. Over 600 cancer patients had operations facilitated through the hub in the year to March 2021.
• ACCEND Programme Aspirant Cancer Career and Education Development Programme supporting the supportive and assistive cancer care workforce with training, career pathways, and capabilities, delivered through the NHS ACCEND Learning Hub.
• Accelerated Endoscopy Training Model Pilot project in which experienced gastroscopists travel across the region supervising additional training lists to accelerate endoscopist sign-off and address pandemic-era diagnostic backlogs. Delivered in partnership with Cheshire & Merseyside Endoscopy Network.
• Rapid Diagnostic Services (RDS) Diagnostic services bringing together equipment and expertise to ensure cancer is diagnosed or ruled out quickly. Eight key components including early identification, timely referral, coordinated testing, and access to clinical trials.
• Faecal Immunochemical Test (FIT) Stool test used to detect faecal occult blood as part of bowel cancer diagnosis. Enables GPs to assess bowel cancer risk in patients with lower-risk symptoms and triage higher-risk patients in secondary care.

Quantifiable outcome

• 77% of lung cancers detected through TLHC programme diagnosed at stages 1 and 2
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

16 partnerships are on record, tiered core and major.

• The Clatterbridge Cancer Centre NHS Foundation TrustcoreStrategic or Co-development PartnerHost organisation for Cheshire and Merseyside Cancer Alliance. The Alliance is hosted by this NHS Foundation Trust which provides the governance, data protection, and operational framework. The Trust's new state-of-the-art cancer hospital opened in Liverpool's Knowledge Quarter.
• The Walton Centre NHS Foundation TrustcoreStrategic or Co-development PartnerNeuro-oncology specialist hospital in Liverpool providing Specialist MDT for brain tumour diagnosis. Collaborated on Emergency Brain Tumour Pathway with STHK and now supporting implementation across other trusts in the region.
• Liverpool Heart and Chest Hospital NHS Foundation TrustcoreStrategic or Co-development PartnerService provider for the Targeted Lung Health Check programme across Cheshire and Merseyside, operating mobile CT scanning vans and providing expert clinical team.
• NHS EnglandcoreStrategic or Co-development PartnerPrimary funder of Cancer Alliance programmes including TLHC, Lynch syndrome pathway, and endoscopy training. Sets national cancer strategy and Long Term Plan targets.
• Health Education EnglandcoreStrategic or Co-development PartnerHEE is funding the Cancer Support Worker Framework project including North West accredited learning programme, skills passport and education framework for CSWs.
• Macmillan Cancer SupportmajorStrategic or Co-development PartnerCharitable partner providing support for cancer patients and families, collaboration on resources and education through The Cancer Academy platform.
• Cancer Research UKmajorStrategic or Co-development PartnerCharitable partner contributing resources to The Cancer Academy platform and collaborating on cancer awareness campaigns.
• Cheshire & Merseyside Endoscopy NetworkcoreStrategic or Co-development PartnerC&MEN partnered with CMCA workforce team on accelerated endoscopy training pilot project funded by HEE to address pandemic backlog.
• Roy Castle Lung Cancer FoundationmajorStrategic or Co-development PartnerCharity running engagement days with mobile inflatable lungs to promote lung health awareness and TLHC programme uptake.
• Warrington Voluntary ActionmajorChannel Partner/ Reseller/ DistributorVCSE body promoting Early Diagnosis Community Engagement project funding and assigning grants to grassroots organisations in Warrington.
• One KnowsleymajorChannel Partner/ Reseller/ DistributorVCSE body promoting Early Diagnosis Community Engagement project funding and assigning grants to grassroots organisations in Knowsley.
• Halton and St Helens Voluntary and Community ActionmajorChannel Partner/ Reseller/ DistributorVCSE body promoting Early Diagnosis Community Engagement project funding and assigning grants to grassroots organisations in Halton.
• North West Genomic Medicine Service AlliancecoreStrategic or Co-development PartnerLeading the development of regional expert centre to support complex Lynch syndrome cases and hold MDT meetings across the region.
• Cheshire and Merseyside Pathology NetworkcoreStrategic or Co-development PartnerPartner in implementing Lynch syndrome optimal pathway for colorectal and endometrial tumour groups using immunohistochemistry testing.
• The Brain Tumour CharitymajorStrategic or Co-development PartnerThird sector partner ensuring Emergency Brain Tumour Pathway development is consistent with patient and carer needs.
• brainstrustmajorStrategic or Co-development PartnerThird sector partner collaborating on Emergency Brain Tumour Pathway development ensuring consistency with patient needs.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/CMCaAlliance
• YouTubeyoutube.com/channel/UCbklFyEC5cFjiKYAaYYZD-w
• Facebookfacebook.com/CheshireMerseysideCancerAlliance
• LinkedInlinkedin.com/company/cheshire-merseyside-cancer-alliance

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cheshire and Merseyside Cancer Alliance